Ypsomed Holding AG (XSWX:YPSN) Beneish M-Score: -2.86 (As of Jun. 25, 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
91 GF Score
Price CHF353.00
GF Value CHF397.48
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Beneish M-Score?

Ypsomed Holding AG XSWX:YPSN +1.91% 91 Beneish M-Score is -2.86 as of Jun. 25, 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 91/100 and a GF Value™ of CHF397.48 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 765 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 72.03% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.86 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Ypsomed Holding AG's Beneish M-Score or its related term are showing as below:

XSWX:YPSN' s Beneish M-Score Range Over the Past 10 Years
Min: -3.05   Med: -2.69   Max: -2.16
Current: -2.86

During the past 13 years, the highest Beneish M-Score of Ypsomed Holding AG was -2.16. The lowest was -3.05. And the median was -2.69.


Ypsomed Holding AG Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG Beneish M-Score Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.73 -2.77 -2.85 -2.33 -2.86

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.85 0.00 -2.33 0.00 -2.86

XSWX:YPSN vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Beneish M-Score falls into.


XSWX:YPSN
91GF Score
Ypsomed Holding AG XSWX:YPSN
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ypsomed Holding AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9688+0.528 * 0.9062+0.404 * 0.5462+0.892 * 0.9761+0.115 * 1.414
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7337+4.679 * -0.062997-0.327 * 0.6832
=-2.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was CHF192.4 Mil.
Revenue was CHF731.0 Mil.
Gross Profit was CHF314.6 Mil.
Total Current Assets was CHF321.2 Mil.
Total Assets was CHF1,346.6 Mil.
Property, Plant and Equipment(Net PPE) was CHF827.7 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF82.2 Mil.
Selling, General, & Admin. Expense(SGA) was CHF89.9 Mil.
Total Current Liabilities was CHF300.5 Mil.
Long-Term Debt & Capital Lease Obligation was CHF111.8 Mil.
Net Income was CHF221.9 Mil.
Gross Profit was CHF0.0 Mil.
Cash Flow from Operations was CHF306.8 Mil.
Total Receivables was CHF203.5 Mil.
Revenue was CHF748.9 Mil.
Gross Profit was CHF292.1 Mil.
Total Current Assets was CHF426.9 Mil.
Total Assets was CHF1,330.3 Mil.
Property, Plant and Equipment(Net PPE) was CHF545.8 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF79.9 Mil.
Selling, General, & Admin. Expense(SGA) was CHF125.5 Mil.
Total Current Liabilities was CHF496.2 Mil.
Long-Term Debt & Capital Lease Obligation was CHF100.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(192.427 / 730.982) / (203.481 / 748.866)
=0.263245 / 0.271719
=0.9688

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(292.066 / 748.866) / (314.606 / 730.982)
=0.390011 / 0.430388
=0.9062

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (321.157 + 827.738) / 1346.597) / (1 - (426.948 + 545.814) / 1330.341)
=0.146816 / 0.268787
=0.5462

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=730.982 / 748.866
=0.9761

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(79.942 / (79.942 + 545.814)) / (82.211 / (82.211 + 827.738))
=0.127753 / 0.090347
=1.414

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(89.907 / 730.982) / (125.54 / 748.866)
=0.122995 / 0.16764
=0.7337

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((111.769 + 300.539) / 1346.597) / ((100 + 496.186) / 1330.341)
=0.306185 / 0.448145
=0.6832

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(221.927 - 0 - 306.759) / 1346.597
=-0.062997

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ypsomed Holding AG has a M-score of -2.86 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.86 mean?
Ypsomed Holding AG (XSWX:YPSN) has a Beneish M-Score of -2.86 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ypsomed Holding AG and its competitors. According to the industry distribution chart, Ypsomed Holding AG ranks #214 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 28%.
Is Ypsomed Holding AG's Beneish M-Score too high?
Ypsomed Holding AG's current Beneish M-Score is -2.86. Based on the distribution chart, Ypsomed Holding AG ranks #214 out of 765 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #214 out of 765 companies for Beneish M-Score. This puts Ypsomed Holding AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current Beneish M-Score is -2.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF397.48, compared to a current price of CHF353.00 — trading 11.2% below its estimated fair value. The current Beneish M-Score is -2.86. Ypsomed Holding AG's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Beneish M-Score is -2.86 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF353.00 is trading 11.2% below its estimated GF Value™ of CHF397.48. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:YPSN:

  • Beneish M-Score: -2.86
  • GF Value™: CHF397.48 vs. price of CHF353.00 (11.2% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
91GF Score

Get the complete analysis for XSWX:YPSN

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF353.00
Price
CHF397.48
GF Value